1. Home
  2. ANEB vs ILLR Comparison

ANEB vs ILLR Comparison

Compare ANEB & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANEB
  • ILLR
  • Stock Information
  • Founded
  • ANEB 2020
  • ILLR 2015
  • Country
  • ANEB United States
  • ILLR United States
  • Employees
  • ANEB N/A
  • ILLR N/A
  • Industry
  • ANEB Biotechnology: Pharmaceutical Preparations
  • ILLR Investment Managers
  • Sector
  • ANEB Health Care
  • ILLR Finance
  • Exchange
  • ANEB Nasdaq
  • ILLR Nasdaq
  • Market Cap
  • ANEB 98.6M
  • ILLR 113.7M
  • IPO Year
  • ANEB 2021
  • ILLR N/A
  • Fundamental
  • Price
  • ANEB $2.30
  • ILLR $0.92
  • Analyst Decision
  • ANEB Buy
  • ILLR
  • Analyst Count
  • ANEB 2
  • ILLR 0
  • Target Price
  • ANEB $8.00
  • ILLR N/A
  • AVG Volume (30 Days)
  • ANEB 124.0K
  • ILLR 2.0M
  • Earning Date
  • ANEB 11-12-2025
  • ILLR 11-13-2025
  • Dividend Yield
  • ANEB N/A
  • ILLR N/A
  • EPS Growth
  • ANEB N/A
  • ILLR N/A
  • EPS
  • ANEB N/A
  • ILLR N/A
  • Revenue
  • ANEB N/A
  • ILLR $45,244,000.00
  • Revenue This Year
  • ANEB N/A
  • ILLR N/A
  • Revenue Next Year
  • ANEB N/A
  • ILLR N/A
  • P/E Ratio
  • ANEB N/A
  • ILLR N/A
  • Revenue Growth
  • ANEB N/A
  • ILLR N/A
  • 52 Week Low
  • ANEB $0.80
  • ILLR $0.40
  • 52 Week High
  • ANEB $3.42
  • ILLR $6.28
  • Technical
  • Relative Strength Index (RSI)
  • ANEB 42.33
  • ILLR 53.43
  • Support Level
  • ANEB $2.34
  • ILLR $0.74
  • Resistance Level
  • ANEB $2.47
  • ILLR $1.01
  • Average True Range (ATR)
  • ANEB 0.12
  • ILLR 0.17
  • MACD
  • ANEB -0.02
  • ILLR -0.03
  • Stochastic Oscillator
  • ANEB 13.49
  • ILLR 19.64

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.

About ILLR Triller Group Inc. Common Stock

Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.

Share on Social Networks: